Ipsen to restart dosing of palovarotene in FOP studies

Ipsen to restart dosing FOP patients aged 14 years and above with palovarotene. Credit: Steve Buissinne from Pixabay.



  • Ipsen to restart dosing of palovarotene in FOP studies